Zymeworks Inc (NAS:ZYME)
$ 23.54 +0.39 (+1.68%) Market Cap: 1.68 Bil Enterprise Value: 1.43 Bil PE Ratio: 0 PB Ratio: 21.38 GF Score: 54/100

Zymeworks Inc to Acquire Theravance Biopharma Inc Transcript

Jun 29, 2026 / 12:30 PM GMT
Release Date Price: $24.1 (-0.21%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ZYME.OQ - Zymeworks Inc
Zymeworks Inc to Acquire Theravance Biopharma Inc
Jun 29, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by. This is the conference operator. Welcome to ZymeWorks' conference call and webcast to discuss the acquisition of TheraVance Biopharma. As a reminder, all participants are in a listen-only mode, and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. I would now like to turn the conference over to Shrenelle Inamdar, Vice President of Investor.

For now, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Good afternoon, everyone, and thank you for joining.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot